Skip to main content
OpenTrials

Clinical trial condition

Stomach Diseases

Explore clinical trials studying Stomach Diseases. Study availability and eligibility vary by location and protocol.

2,578 public trials 586 recruiting studies
Refine in advanced search Browse all conditions

Stomach Diseases trial results

Active, Not Recruiting

XELOX for 4 Months Versus 6 Months in Gastric Cancer (LOMAC)

NCT03399110

Conditions
Digestive System Diseases, Digestive System Neoplasms, Gastric Cancer, +6 more
Locations
  • Sun Yat-sen University Cancer Center Guangzhou, China
  • The First Affiliated Hospital of Anhui Medical University Hefei, China
  • The First Affiliated Hospital of University of Science and Technology of China Hefei, China
  • Jiangsu Cancer Hospital Nanjing, China
View Trial Details
Active, Not Recruiting

Pembrolizumab, Capecitabine, and Radiation Therapy in Treating Patients With Mismatch-Repair Deficient and Epstein-Barr Virus Positive Gastric Cancer

NCT03257163

Conditions
Digestive System Diseases, Digestive System Neoplasms, Epstein-Barr Virus Positive, +16 more
Locations
  • Emory University Atlanta, Georgia, United States
  • RWJBarnabas Health - Robert Wood Johnson University Hospital, Hamilton Hamilton, New Jersey, United States
  • Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States
  • Montefiore Medical Center The Bronx, New York, United States
View Trial Details
Active, Not Recruiting

QUILT-3.055: A Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment With Immune Checkpoint Inhibitors

NCT03228667

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +79 more
Locations
  • Alaska Clinical Research Center Anchorage, Alaska, United States
  • Genesis Cancer Center Hot Springs, Arkansas, United States
  • Chan Soon-Shiong Institute for Medicine El Segundo, California, United States
  • MemorialCare Health System Fountain Valley, California, United States
View all 35 locations
View Trial Details
Active, Not Recruiting

First in Human Study of TORL-2-307-ADC in Participants With Advanced Cancer

NCT05156866

Conditions
Advanced Solid Tumor, Digestive System Diseases, Digestive System Neoplasms, +13 more
Locations
  • Providence St. Jude Medical Center Fullerton, California, United States
  • UCLA - JCCC Clinical Research Unit Los Angeles, California, United States
  • Torrance Memorial Medical Torrance, California, United States
  • Fort Wayne Medical Oncology and Hematology Fort Wayne, Indiana, United States
View Trial Details
Active, Not Recruiting

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

NCT04198766

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +56 more
Locations
  • City of Hope Duarte, California, United States
  • Los Angeles Cancer Network Glendale, California, United States
  • California Research Institute Los Angeles, California, United States
  • Valkyrie Clinical Trials Los Angeles, California, United States
View all 42 locations
View Trial Details
Active, Not Recruiting

A Trial to Evaluate Safety and Tolerability of TST001 in Advanced or Metastatic Solid Tumors

NCT04396821

Conditions
Advanced Cancer, Digestive System Diseases, Digestive System Neoplasms, +13 more
Locations
  • Banner MD Anderson Gilbert, Arizona, United States
  • University of Arizona Tucson, Arizona, United States
  • Yale University New Haven, Connecticut, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
View all 18 locations
View Trial Details

Related conditions